Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)
Key facts
- Where
- Edegem, BelgiumSee the site
Where in Belgium
- University Hospital AntwerpEdegem, BelgiumContact: Karolien Dams, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Antwerp
- Trial code
- NCT06345547
- Record updated
- 1 May 2026
- Original description
The goal of this observational cohort study is to learn about loss of muscle mass and muscle strength (sarcopenia) in patients with cirrhosis. The main question[s] it aims to answer are:Read full original descriptionShow less
Prospective Observational Cohort Survey to Assess the Prevalence and Development of Sarcopenia and the Correlation of Muscle Mass and Outcome in Patients With Cirrhosis by Skeletal Muscle Ultrasound.
The goal of this observational cohort study is to learn about loss of muscle mass and muscle strength (sarcopenia) in patients with cirrhosis. The main question[s] it aims to answer are:
* what is the prevalence and development of sarcopenia in cirrhosis? * what is the role of malnutrition? Participants will
* undergo a muscle ultrasound of the lower and upper limb muscles * handgrip strength will be measured * malnutrition screening and assessment * complete a questionnaire to assess quality of life
Inclusion: diagnosis of cirrhosis and follow-up in the University Hospital of Antwerp.
Exclusion: a decision made prior to inclusion to stop further treatment of the patient within the next 24 hours; no complete remission of malignancy including hepatocellular carcinoma within the past 12 months; known patient will against participation in the study or against the measures applied in the study.